FDA Says Preapproval Inspections Will Not Trigger Surveillance Audits
Executive Summary
Decisions to conduct GMP surveillance audits for currently marketed products are not triggered by pending NDAs subject to preapproval inspections, FDA official confirms. The two types of inspections are “delinked” from each other.